497
Participants
Start Date
October 9, 2020
Primary Completion Date
January 11, 2021
Study Completion Date
February 8, 2021
VASCADE MVP VVCS
The VASCADE MVP Venous Vascular Closure System (VVCS) is indicated for the percutaneous closure of femoral venous access sites while reducing time to ambulation, total post-procedure time, time to hemostasis, and time to discharge eligibility in patients who have undergone catheter-based procedures utilizing 6 - 12F inner diameter (maximum 15F OD) procedural sheaths, with single or multiple access sites in one or both limbs.
MedStar Washington, Washington D.C.
Cleveland Clinic, Cleveland
Coastal Cardiology, San Luis Obispo
Lahey Clinic, Burlington
Lead Sponsor
Cardiva Medical, Inc.
INDUSTRY